Annual vs Quarterly Biomarker Cadence
Annual cadence is appropriate for steady-state wellness monitoring. Quarterly cadence is the provider-reviewed default during active optimization (initiation, dose changes, hormone titration) and for high-variability biomarkers.
Annual cadence is appropriate during stable steady-state monitoring with no active intervention changes.
Quarterly cadence is required at initiation and during active optimization. It is the provider-reviewed default in the oMeds Vitality membership.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Is annual enough on TRT?
Not at initiation. Steady-state may shift to semi-annual under provider review.
Why quarterly during GLP-1?
To track lean mass, glycemic markers, and lipid trajectory during titration.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment